Clinical significance of trisomy 8 that emerges during therapy in chronic myeloid leukemia

Por Wang, W, Chen, Z, Hu, Z, Yin, C C, Li, S, Bai, S, Bueso-Ramos, C E, Medeiros, L J, Hu, S
Publicado no Blood Cancer J (2016)

AML with t(10;11): A pathological entity with distinct clinical presentation

Por DiNardo, CD, Tang, G, Pemmaraju, N, Wang, S, Pike, A, Garcia-Manero, G, Cortes, J, Bueso-Ramos, C, Kantarjian, H
Publicado no Clin Lymphoma Myeloma Leuk (2014)

Myelodysplastic/Myeloproliferative Neoplasms, Unclassifiable (MDS/MPN, U): Natural history and clinical outcome by treatment strategy

Por DiNardo, CD, Daver, N, Jain, N, Pemmaraju, N, Bueso-Ramos, C, Yin, CC, Pierce, S, Jabbour, E, Cortes, JE, Kantarjian, HM, Garcia-Manero, G, Verstovsek, S
Publicado em 2014

A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome

Por Vadhan-Raj, S., Fayad, L. E., Fanale, M. A., Pro, B., Rodriguez, A., Hagemeister, F. B., Bueso-Ramos, C. E., Zhou, X., McLaughlin, P. W., Fowler, N., Shah, J., Orlowski, R. Z., Samaniego, F., Wang, M., Cortes, J. E., Younes, A., Kwak, L. W., Sarlis, N. J., Romaguera, J. E.
Publicado em 2012